0000899243-18-029300.txt : 20181119
0000899243-18-029300.hdr.sgml : 20181119
20181119161050
ACCESSION NUMBER: 0000899243-18-029300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181115
FILED AS OF DATE: 20181119
DATE AS OF CHANGE: 20181119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amorrortu Pedro Alvaro
CENTRAL INDEX KEY: 0001727552
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38360
FILM NUMBER: 181192598
MAIL ADDRESS:
STREET 1: C/O SOLID BIOSCIENCES, LLC
STREET 2: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Solid Biosciences Inc.
CENTRAL INDEX KEY: 0001707502
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 900943402
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-337-4682
MAIL ADDRESS:
STREET 1: 141 PORTLAND STREET, FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Solid Biosciences, LLC
DATE OF NAME CHANGE: 20170524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-15
0
0001707502
Solid Biosciences Inc.
SLDB
0001727552
Amorrortu Pedro Alvaro
C/O SOLID BIOSCIENCES INC.
141 PORTLAND STREET, FIFTH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
Chief Operating Officer
Common Stock
2018-11-15
4
S
0
4700
30.6057
D
176046
D
Common Stock
2018-11-15
4
S
0
4300
31.0771
D
171746
D
The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form.
/s/ Pedro Alvaro Amorrortu
2018-11-19